DMARDs

Lilly India enters the autoimmune segment with Olumiant™, a new once-daily oral therapy for Rheumatoid Arthritis

Mumbai, November 11, 2018: Eli Lilly and Company (India) Pvt. Ltd. (“Lilly India”) announced the launch of Olumiant™ (baricitinib). This…

6 years ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420